Toggle light / dark theme

Summary: Researchers have designed a new method of converting non-neural cells into functioning neurons that are able to form synapses, dispense dopamine, and restore the function of neurons undermined by Parkinson’s associated destruction of dopaminergic cells.

Neurodegenerative diseases damage and destroy neurons, ravaging both mental and physical health. Parkinson’s disease, which affects over 10 million people worldwide, is no exception. The most obvious symptoms of Parkinson’s disease arise after the illness damages a specific class of neuron located in the midbrain. The effect is to rob the brain of dopamine—a key neurotransmitter produced by the affected neurons.

In new research, Jeffrey Kordower and his colleagues describe a process for converting non-neuronal cells into functioning neurons able to take up residence in the brain, send out their fibrous branches across neural tissue, form synapses, dispense dopamine and restore capacities undermined by Parkinson’s destruction of dopaminergic cells.

Researchers at Meta’s Artificial Intelligence Research Lab (Facebook) in the U.S. and at the University of Twente’s Neuromechanical Modelling and Engineering Lab in the Netherlands (led by Prof.dr.ir Massimo Sartori), have co-developed the open-source framework MyoSuite, which combines advanced musculoskeletal models with advanced artificial intelligence (AI). The AI-powered digital models in MyoSuite can learn to execute complex movements and interactions with assistive robots, that would otherwise require long experimentations on real human subjects.

Modeling and simulation are now as important to human health technologies as they have been for the advancement of modern automotive industry. Prof. Massimo Sartori: “If we could predict the outcome of a robotic therapy beforehand, then we could optimize it for a patient and deliver a truly personalized and cost-effective treatment.”

MyoSuite supports the co-simulation of AI-powered musculoskeletal systems physically interacting with such as exoskeletons. With MyoSuite you can simulate biological phenomena, e.g., muscle fatigue, muscle sarcopenia, tendon tear and tendon reaffirmation. Moreover, you can simulate how assistive robots could be designed and controlled to restore movement following impairment.

Artificial intelligence (AI) is spreading through society into some of the most important sectors of people’s lives – from health care and legal services to agriculture and transportation.1 As Americans watch this proliferation, they are worried in some ways and excited in others.

In broad strokes, a larger share of Americans say they are “more concerned than excited” by the increased use of AI in daily life than say the opposite. Nearly half of U.S. adults (45%) say they are equally concerned and excited. Asked to explain in their own words what concerns them most about AI, some of those who are more concerned than excited cite their worries about potential loss of jobs, privacy considerations and the prospect that AI’s ascent might surpass human skills – and others say it will lead to a loss of human connection, be misused or be relied on too much.

But others are “more excited than concerned,” and they mention such things as the societal improvements they hope will emerge, the time savings and efficiencies AI can bring to daily life and the ways in which AI systems might be helpful and safer at work. And people have mixed views on whether three specific AI applications are good or bad for society at large.

The bottom of the ocean is full of mysteries but scientists have recently uncovered one of its best-kept secrets. For 25 years, drug hunters have been searching for the source of a natural chemical that had shown promise in initial studies for treating cancer. Now, researchers at University of Utah Health report that easy-to-find soft corals—flexible corals that resemble underwater plants—make the elusive compound.

Identifying the source allowed the researchers to go a step further and find the animal’s DNA code for synthesizing the chemical. By following those instructions, they were able to carry out the first steps of re-creating the soft coral chemical in the laboratory.

“This is the first time we have been able to do this with any drug lead on Earth,” says Eric Schmidt, Ph.D., professor of medicinal chemistry at U of U Health. He led the study with Paul Scesa, Ph.D., postdoctoral scientist and first author, and Zhenjian Lin, Ph.D., assistant research professor.

Cell-Based Dairy Bio-Products For Health & Nutrition — Dr. Aletta Schnitzler, Ph.D. — CSO — Turtletree Labs


Dr. Aletta Schnitzler, PhD. is the Chief Scientific Officer at TurtleTree Labs (https://turtletree.com/) where she leads the R&D teams and spearheads an innovation roadmap to bring nutritious cell-based dairy and meat alternatives to market.

TurtleTree is a biotech company dedicated to producing a new generation of nutrition—one that’s better for the planet, better for the animals, and better for people everywhere. Utilizing its proprietary, cell-based technology, the company is creating “better-for-you” milk ingredients sustainably and affordably, with benefits that extend beyond the dining table and into the heart of humanity.

UK’s National Grid Electricity Transmission (NGET) is launching trials to fully automate the corrosion inspection of electricity transmission pylons with the help of autonomous drones.

NGET owns 21,900 steel lattice pylons that carry overhead transmission conductor wires in England and Wales. Transmission pylon steelwork conditions can deteriorate through corrosion, so periodic assessments are made to understand the health of the network. NGET inspects around 3,650 steel lattice pylons each year, capturing high definition still color images of steelwork using helicopters and manually-operated drones.

Preparedness For Emerging Diseases & Zoonoses — Dr. Maria Van Kerkhove, Ph.D., Emerging Diseases and Zoonoses Unit Head, World Health Organization, (WHO)


Dr. Maria Van Kerkhove, Ph.D., (https://www.imperial.ac.uk/people/m.vankerkhove) is an infectious disease epidemiologist who serves as the technical lead for the COVID-19 response at the World Health Organization (https://www.who.int/en/), where she develops guidance, training programs, and information products for the continuously evolving state of the pandemic, as well serving as the Emerging Diseases and Zoonoses Unit Head.

Dr. Van Kerkhove began her journey in global health given her interest in viruses and how they infect and impact both humans and animals. She received her undergraduate degree in biological sciences from Cornell University, her master’s degree in epidemiology from Stanford University, and a PhD in infectious disease epidemiology from the London School of Tropical Hygiene and Medicine where she authored her PhD on pathogenic avian influenza H5N1 in Cambodia.

We should really be looking to nuclear power FAR more than we have been. Until fusion finally comes of age anyway. It’s one of the most annoyingly counterproductive issue with many environmentalists I tend to have.


Extreme temperatures and ongoing drought could cause the power grid to buckle across vast areas of the country this summer, potentially leading to electricity shortages and blackouts, a US power grid regulator said Wednesday.

NERC, a regulating authority that oversees the health of the nation’s electrical infrastructure, says in its 2022 Summer Reliability Assessment that extreme temperatures and ongoing drought could cause the power grid to buckle. High temperatures, the agency warns, will cause the demand for electricity to rise. Meanwhile, drought conditions will lower the amount of power available to meet that demand.

“Industry prepares its equipment and operators for challenging summer conditions. Persistent, extreme drought and its accompanying weather patterns, however, are out of the ordinary and tend to create extra stresses on electricity supply and demand,” said Mark Olson, NERC’s manager of Reliability Assessments.

A Massachusetts resident has tested positive for monkeypox, health officials confirmed Wednesday, making it the first case of the rare virus detected in the United States this year.

According to a release from the Massachusetts Department of Public Health, the patient is an adult male who recently traveled to Canada. The department completed initial testing Tuesday and was confirmed by the Centers for Disease Control and Prevention.

“The case poses no risk to the public, and the individual is hospitalized and in good condition,” MDPH stated in a press release. “DPH is working closely with the CDC, relevant local boards of health, and the patient’s health care providers to identify individuals who may have been in contact with the patient while he was infectious.”

The relentless evolution of the coronavirus, which has spawned new variants to fuel fresh surges of disease every four to six months, could in the not-distant future propel the virus to overtake measles as the most contagious of all known infections.

Increasing infectiousness does not necessarily make the virus deadlier, but it could make it harder to control, and leave communities vulnerable to the repeated waves of illness that have defined the pandemic.

The variants now dominating around the world may be five to 10 times more infectious than the original virus that sparked the pandemic in China in late 2019, health experts believe. Lately each variant has outpaced its parent — omicron, with its massive evolutionary jump, was about three times more infectious than delta. Its subvariants — BA.2 and BA.2.12.1, which are driving the latest surge in the Bay Area — are each more infectious still, by 20% to 30%.